NASDAQ · Financial Statements
Kezar Life Sciences (KZR) Financial Statements
$7.29
NASDAQ: KZR
Market Cap $53.86M
Overview Financials Dividend Kezar Life Sciences most recently reported annual revenue of $0, net profit of $-56.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $7.0M $0 $0 Operating Profit $-55.0M $-71.0M $-111.0M $-91.0M $-52.0M Net Profit $-55.0M $-68.0M $-102.0M $-84.0M $-56.0M EPS $-1.04 $-1.01 $-1.40 $-1.15 $-7.66 Op Margin — — -1591.8% — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $218.0M $300.0M $221.0M $145.0M $77.0M Total Liabilities $21.0M $30.0M $34.0M $28.0M $7.0M Cash $63.0M $40.0M $35.0M $42.0M $72.0M Borrowings $14.0M $21.0M $19.0M $16.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-42.0M $-59.0M $-82.0M $-74.0M $-52.0M Investing Cash Flow $-29.0M $-93.0M $74.0M $80.0M $92.0M Financing Cash Flow $2.0M $1.0M $0 $0 $0 Net Cash Flow $42.0M $-22.0M $-5.0M $6.0M $30.0M Free Cash Flow $-43.0M $-60.0M $-83.0M $-74.0M $-52.0M
Valuation & Return Ratios
Metric Value PEG Ratio — EV / EBITDA — FCF Yield -96.24% Quick Ratio 10.86 Interest Coverage — Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock